Israel: Last Participant Receives First Treatment

On January 13, 2016, the tenth and final subject received their first treatment in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this …

Israel: Ninth Participant Treated; Enrollment Completed

On December 10, 2015, the ninth participant was treated in our Israeli study of MDMA-assisted psychotherapy for PTSD. The tenth and final participant was enrolled on December 16. Led by Principal Investigator …

Israel: Ninth Subject Enrolled

On November 4, 2015, the ninth subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study will treat …

Canada: Enrollment Concluded

On November 2, 2015, enrollment was concluded in our study of MDMA-assisted psychotherapy for PTSD from sexual assault, violent crime, military service, or any other cause, taking place in Vancouver, Canada. …

Israel: Eighth Subject Treated

On October 6, the eighth subject was treated in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study will treat up to …

Boulder: Last Two Subjects Treated

On October 2 and 9, 2015, the last two subjects were treated in our ongoing study of MDMA-assisted psychotherapy for 23 subjects with PTSD from sexual assault, violent crime, war, natural disasters, or …

Israel: Eighth Subject Enrolled

On September 4, 2015, the eighth subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study will treat …